Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral BCAA Supplementation for Decompensated Cirrhosis
NCT06121479Phase 3Enrolling by invitation
- Sponsor
- Mahidol University
- Start
- Nov 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Branchamin in decompensated cirrhosis, ascites, sponsored by Mahidol University. Started Nov 2023; status: enrolling by invitation.
02
Drugs
Branchamin
03
Conditions
decompensated cirrhosisascites
Beyond the preview
Go deeper on NCT06121479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06121479.